Depresszió: vizsgálatok itt: Lettország

2 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  Where

  Jelgava, Liepaja, Siguldas Pagasts

  Életkor

  18 év and over

  People

  850 worldwide

  Run by

  Neurocrine Biosciences

  See details and how to joinNCT06966401 · EU 2024-519423-24-00
• 3. fázisTaking people
  NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  Where

  Jelgava, Liepaja, Siguldas Pagasts

  Életkor

  18 év and over

  People

  200 worldwide

  Run by

  Neurocrine Biosciences

  See details and how to joinNCT06963021 · EU 2024-519421-37-00